References
- Baum, M. K., Jayaweera, D. T., Duan, R., Sales, S., Lai, S., Rafie, C., … Campa, A. (2008). Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Journal of Addictive Diseases, 27(2), 37–48. https://doi.org/10.1300/J069v27n02_05
- Beaulieu, T., Ti, L., Milloy, M. J., Nosova, E., Wood, E., & Hayashi, K. (2018). Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada. Substance Abuse Treatment, Prevention, and Policy, 13(1), 3. https://doi.org/10.1186/s13011-018-0142-9
- Berto, A., Day, J., Chau, N. V. V., Thwaites, G. E., My, N. N., Baker, S., & Darton, T. C. (2017). Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: A systematic review. BMC Infectious Diseases, 17(1), 260. https://doi.org/10.1186/s12879-017-2360-6
- Broeckaert, L., & Challacombe, L. (2015). Does multidisciplinary care improve health outcomes among people living with HIV and or HCV? A review of the evidence. Prevention in Focus. Retrieved from: https://www.catie.ca/en/pif/fall-2015/does-multidisciplinary-care-improve-health-outcomes-among-people-living-hiv-andor-hcv-
- Bruggmann, P., & Grebely, J. (2015). Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy, 26, S22–S26. https://doi.org/10.1016/j.drugpo.2014.08.014
- Bruno, G., & Saracino, A. (2017). Direct-acting antivirals for HIV/HCV Co-infected individuals: As good as it gets? Current HIV Research, 15(6), 422–433. https://doi.org/10.2174/1570162X15666171108125255
- Chu, C. E., Wu, F., He, X., Zhou, K., Cheng, Y., Cai, W., … Tucker, J. D. (2016, April). Hepatitis C virus treatment access among human immunodeficiency virus and hepatitis C virus (HCV)-coinfected people who inject drugs in Guangzhou, China: Implications for HCV treatment expansion. In Open forum infectious diseases (Vol. 3, No. 2, p. ofw065). Oxford University Press.
- Clement, S., Brohan, E., Jeffery, D., Henderson, C., Hatch, S. L., & Thornicroft, G. (2012). Development and psychometric properties the Barriers to Access to Care Evaluation scale (BACE) related to people with mental ill health. BMC Psychiatry, 12(1), 36. https://doi.org/10.1186/1471-244X-12-36
- Collins, S., Mertenskoetter, T., Loeliger, E., Tressler, R., Weller, I., Friis-Møller, N., … Sawitz, A. (2006). Liver-related deaths in persons infected with the human immunodeficiency virus. Archives of Internal Medicine, 166(15), 1632–1641. https://doi.org/10.1001/archinte.166.15.1632
- Doyle, J. S., Aspinall, E., Liew, D., Thompson, A. J., & Hellard, M. E. (2013). Current and emerging antiviral treatments for hepatitis C infection. British Journal of Clinical Pharmacology, 75(4), 931–943. https://doi.org/10.1111/j.1365-2125.2012.04419.x
- Easterbrook, P. J., Roberts, T., Sands, A., & Peeling, R. (2017). Diagnosis of viral hepatitis. Current Opinion in HIV and AIDS, 12(3), 302–314. https://doi.org/10.1097/COH.0000000000000370
- Easterbrook, P., Johnson, C., Figueroa, C., & Baggaley, R. (2016). HIV and hepatitis testing: Global progress, challenges, and future directions. AIDS Reviews, 18(1), 3–14.
- Edlin, B. R. (2004). Hepatitis C prevention and treatment for substance users in the United States: Acknowledging the elephant in the living room. International Journal of Drug Policy, 15(2), 81–91. https://doi.org/10.1016/j.drugpo.2003.10.007
- Fialho, R., Pereira, M., Rusted, J., & Whale, R. (2017). Depression in HIV and HCV co-infected patients: A systematic review and meta-analysis. Psychology, Health & Medicine, 22(9), 1089–1104. https://doi.org/10.1080/13548506.2017.1280177
- Fleiss, J. L. (1981). Statistical methods for rates and proportions (2nd ed.). John Wiley & Sons.
- Hepworth, J., Bain, T., & Driel, M. (2013). Hepatitis C, mental health and equity of access to antiviral therapy: A systematic narrative review. International Journal for Equity in Health, 12(1), 92. https://doi.org/10.1186/1475-9276-12-92
- Hernando, V., Perez-Cachafeiro, S., Lewden, C., Gonzalez, J., Segura, F., Oteo, J. A., … Amo, J. (2012). All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection. Journal of Hepatology, 57(4), 743–751. https://doi.org/10.1016/j.jhep.2012.06.010
- Iversen, J., Page, K., Madden, A., & Maher, L. (2015). HIV, HCV and health-related harms among women who inject drugs: Implications for prevention and treatment. JAIDS Journal of Acquired Immune Deficiency Syndromes, 69(01), S176–S181. https://doi.org/10.1097/QAI.0000000000000659
- Kamarulzaman, A., & Altice, F. L. (2015). The challenges in managing HIV in people who use drugs. Current Opinion in Infectious Diseases, 28(1), 10–16. https://doi.org/10.1097/QCO.0000000000000125
- Lekas, H. M., Siegel, K., & Leider, J. (2011). Felt and enacted stigma among HIV/HCV-coinfected adults. Qualitative Health Research, 21(9), 1205–1219. https://doi.org/10.1177/1049732311405684
- Lin, C., Clark, R., Tu, P., Tu, R., Hsu, Y. J., & Nien, H. C. (2019). The disconnect in hepatitis screening: Participation rates, awareness of infection status, and treatment-seeking behavior. Journal of Global Health, 9(1), 010426. https://doi.org/10.7189/jogh.09.010426
- Mojtabai, R., Chen, L. Y., Kaufmann, C. N., & Crum, R. M. (2014). Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders. Journal of Substance Abuse Treatment, 46(2), 268–273. https://doi.org/10.1016/j.jsat.2013.07.012
- Nadol, P., O’connor, S., Duong, H., Le, L. V. N., Thang, P. H., Tram, T. H., … Law, M. (2015). Findings from integrated behavioral and biologic survey among males who inject drugs (MWID)—Vietnam, 2009–2010: Evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus. PloS One, 10(2), e0118304. https://doi.org/10.1371/journal.pone.0118304
- Oramasionwu, C. U., Moore, H. N., & Toliver, J. C. (2014). Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: A review. AIDS Patient Care and STDs, 28(5), 228–239. https://doi.org/10.1089/apc.2014.0033
- Osilla, K. C., Wagner, G., Garnett, J., Ghosh-Dastidar, B., Witt, M., Bhatti, L., & Goetz, M. B. (2011). Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment. AIDS Patient Care and STDs, 25(9), 533–538. https://doi.org/10.1089/apc.2011.0048
- Pham, M. K., Vallo, R., Duong, T. H., Khuat, T. H. O., Jarlais, D. C. D., Peries, M., … Thanh, T. (2018). Psychiatric comorbidities among people who inject drugs in Hai Phong, Vietnam: The need for screening and Innovative Interventions. BioMed Research International, 2018, 8346195. https://doi.org/10.1155/2018/8346195 doi: 10.1155/2018/3570830
- Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., … Vickerman, P. (2016). Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. The Lancet Infectious Diseases, 16(7), 797–808. https://doi.org/10.1016/S1473-3099(15)00485-5
- Poordad, F., & Dieterich, D. (2012). Treating hepatitis C: Current standard of care and emerging direct-acting antiviral agents. Journal of Viral Hepatitis, 19(7), 449–464. https://doi.org/10.1111/j.1365-2893.2012.01617.x
- Pouget, E. R., Hagan, H., & Des Jarlais, D. C. (2012). Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction, 107(6), 1057–1065. https://doi.org/10.1111/j.1360-0443.2011.03765.x
- R Core Team. (2019). R: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/
- Rogal, S. S., Arnold, R. M., Chapko, M., Hanusa, B. V., Youk, A., Switzer, G. E., … Obrosky, D. S. (2016). The patient-provider relationship is associated with hepatitis C treatment eligibility: A prospective mixed-methods cohort study. PloS one, 11(2), e0148596. https://doi.org/10.1371/journal.pone.0148596
- Salmon-Ceron, D., Cohen, J., Winnock, M., Roux, P., Sadr, F. B., Rosenthal, E., … Spire, B. (2012). Engaging HIV-HCV co-infected patients in HCV treatment: The roles played by the prescribing physician and patients’ beliefs (ANRS CO13 HEPAVIH cohort, France). BMC Health Services Research, 12(1), 59. https://doi.org/10.1186/1472-6963-12-59
- Schlabe, S., & Rockstroh, J. K. (2018). Advances in the treatment of HIV/HCV co-infection in adults. Expert Opinion on Pharmacotherapy, 19(1), 49–64. https://doi.org/10.1080/14656566.2017.1419185
- Singh, P. K. (2018). World Hepatitis Day. http://www.searo.who.int/mediacentre/features/2018/rd-message-world-hepatitis-day-2018/en/
- Souliotis, K., Agapidaki, E., Papageorgiou, M., Voudouri, N., & Contiades, X. (2017). Access to treatment for hepatitis C among injection drug users: Results from the cross-sectional HOPE IV study. International Journal for Equity in Health, 16(1), 101. https://doi.org/10.1186/s12939-017-0601-3
- Sulkowski, M. S. (2008). Viral hepatitis and HIV co-infection. Journal of Hepatology, 48(2), 353–367. https://doi.org/10.1016/j.jhep.2007.11.009
- Sulkowski, M. S., Thomas, D. L., Mehta, S. H., Chaisson, R. E., & Moore, R. D. (2002). Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections. Hepatology, 35(1), 182–189. https://doi.org/10.1053/jhep.2002.30319
- Thein, H. H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008). Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis. Aids, 22(15), 1979–1991. https://doi.org/10.1097/QAD.0b013e32830e6d51
- Treloar, C., Rance, J., & Backmund, M. (2013). Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clinical Infectious Diseases, 57(suppl_2), S51–S55. https://doi.org/10.1093/cid/cit263
- Vietnam Ministry of Health. (2010). Guide to alternative treatment for opioid addiction with methadone (Report No. 3140/QĐ-BYT). http://vaac.gov.vn/vanban_detail/Detail/Quyet-dinh-so-3140-QD-BYT-cua-Bo-truong-Bo-Y-te-ngay-30-thang-8-nam-2010
- Vietnam Ministry of Health. (2016). Guide to HCV diagnosis and treatment (Report No. 5012/QĐ-BYT). https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-5012-QD-BYT-chan-doan-dieu-tri-benh-viem-gan-vi-rut-c-2016-322718.aspx
- Vietnam Ministry of Health. (2017). Guide to HIV/AIDS treatment and care (Report No. 5418/QĐ-BYT). https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-5418-QD-BYT-2017-huong-dan-dieu-tri-va-cham-soc-HIV-AIDS-372738.aspx
- Vietnam Ministry of Health. (2018). The list, rate and payment condition of pharmaceutical medicines, biomedicals, radioactive medicines and substance for the participants of social health insurance (Report No. 30/2018/TT-BYT). https://thuvienphapluat.vn/van-ban/Bao-hiem/Thong-tu-30-2018-TT-BYT-thanh-toan-thuoc-hoa-duoc-sinh-pham-cua-nguoi-tham-gia-bao-hiem-y-te-400326.aspx
- Wang, L., Panagiotoglou, D., Min, J. E., DeBeck, K., Milloy, M. J., Kerr, T., … Nosyk, B. (2016). Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting. Drug and Alcohol Dependence, 168, 22–29. https://doi.org/10.1016/j.drugalcdep.2016.08.631
- World Health Organization. (2014). Joint Review of the Health Sector Response to HIV 2014. https://iris.wpro.who.int/bitstream/handle/10665.1/12787/9789290617426_eng.pdf?ua=1
- World Health Organization. (2016). Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. World Health Organization. https://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2016/en/
- Zickmund, S., Hillis, S. L., Barnett, M. J., Ippolito, L., & LaBrecque, D. R. (2004). Hepatitis C virus-infected patients report communication problems with physicians. Hepatology, 39(4), 999–1007. https://doi.org/10.1002/hep.20132
- Zung, W. W. (1965). A self-rating depression scale. Archives of General Psychiatry, 12(1), 63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008